title: Conversion from cyclosporine Sandimmune to cyclosporine Neoral in the stable renal transplant population.
authors.affiliation: Transplant Unit, Cardiff Royal Infirmary, United Kingdom.
authors.forename: P J
authors.initials: PJ
authors.lastname: Griffin
authors.forename: R H
authors.initials: RH
authors.lastname: Moore
authors.forename: W A
authors.initials: WA
authors.lastname: Jurewicz
authors.forename: R H
authors.initials: RH
authors.lastname: Lord
authors.forename: Y
authors.initials: Y
authors.lastname: Webley
authors.forename: J
authors.initials: J
authors.lastname: Jenkins
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004304:Dosage Forms; D016903:Drug Monitoring; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology* / Q000502:physiology; D008297:Male; D008875:Middle Aged
chemical_list: D004304:Dosage Forms; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine